ARTICLE | Clinical News
TOP1630: Ph I/IIa started
March 10, 2017 7:56 PM UTC
TopiVert began a U.S. Phase I/IIa trial to evaluate topical TOP1630....
BCIQ Company Profiles
TopiVert began a U.S. Phase I/IIa trial to evaluate topical TOP1630....
BCIQ Company Profiles